G. Wang

机构：Army Medical University, Southwest Hospital, Affiliated Zhongshan Hospital of Dalian University

发表论文 3 篇 · 总被引 24 次 · h-index 1

代表论文

• 1373MO JUPITER-06: A randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC) (2021 · Annals of Oncology · 被引 24)
• 174P Safety and efficacy of anlotinib plus docetaxel in advanced non-small cell lung cancer patients after failure of first-line chemotherapy: Recent results from the ongoing phase II study (ALTER-L024) (2021 · Journal of Thoracic Oncology)
• Apatinib plus S-1 as second-line or later line treatment for advanced squamous cell lung carcinoma (2018 · Annals of Oncology)